We're pleased to announce the closing of our acquisition of TwelveBio, a gene-editing company based in Denmark. Our team is thrilled to welcome our new colleagues on board. Read more here: https://t.co/20Lq66npuo
Excited about Ensoma's next chapter and our path to developing transformative medicines for patients globally.
Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines - https://t.co/GPEYwAaeID
We're excited to share that Ensoma has been named one of @BosBizJournal's Best Places to Work! Realizing the vision of bringing the power of genomic medicine to every person in need is personal to our team. Interested in joining us? Head over to our #careerspage for more info.
Ensoma believes the future of medicine lies within us. We have a bolder vision for genomic medicine: Treatments as versatile, precise and far-reaching as the body’s own cells. One therapy, one cure – with minimal to no added burden for patients. https://t.co/V8gdFIg0Mg
We're honored to be featured on this year's list of the top life sciences startups to watch. With an approach that will potentially reshape the genomic medicine landscape, 2022 is poised to be a year of progress and growth for Ensoma.
2021 has been an unprecedented year with COVID-19 and the changing work environment. We're happy to offer the next ten days as a chance for employees to relax and spend uninterrupted quality time with loved ones. Cheers to a successful year and to all that's to come in 2022!
This past weekend, we took team building to the next level with 12 Ensoma team members competing in Boston's @SpartanRace together. They took on 20 obstacles over a 5K. A special shout-out to our CSO Rob Peters for spearheading this incredible effort. Well done, team!
Today, Ensoma is thrilled to welcome gene and cell therapy pioneer, Dr. Emile Nuwaysir, as our new CEO to lead our team forward as we advance our bigger, bolder vision for gene therapy. Learn more here. https://t.co/P4P8td46yn
At Ensoma, we believe every person, no matter where they are in the world, should have access to innovative technologies that are changing the way we treat disease. That's why we join the WHO in recognizing #WorldHealthDay
Last week, we had the honor of hosting our first rare disease patient and advocate. Equity and accessibility to treatments for all patients was a key highlight of our discussion. Rare Disease Day and every day, we must listen, advocate and push forward. #RareDiseaseDay
We believe every person, no matter where they are in the world, should have access to innovative technologies that are changing the way we treat disease. That's why we're thrilled to launch Ensoma.
In an industry where most successful entrepreneurs have experienced failures on their way to commercialization, Stu Peltz (@PTCBio), Barbara Fox, (@Rheosrx) @annaprotopapas, & @psoteropoulos take the stage to share their journeys from bench to patient bedside #StateOfPossible2020
This is so true! Blessed to have spent my formative years at an organization like Genzyme where many of us, men AND women, were groomed with P&L accountability.
Roles in which profits and losses hang in the balance are what set executives on the CEO track. Our analysis of executive teams at thousands of America's most valuable companies shows that men overwhelmingly get these jobs. https://t.co/HdnxNqlKD4
This is awesome! How about other investment banks doing this also? Let’s all ask our banker friends to follow suit. Time for change! #rightmattershere
https://t.co/hBRrJWSuMx